UnitedHealth Group (UNH) Q1 2026 earnings summary

Executive summary

• All major business segments exceeded plan for Q1 2026, with strong performance in Medicare and Optum Health; revenues reached $111.7 billion, up 2% year-over-year, and adjusted EPS was $7.23.

• Organization refocused on U.S. healthcare, exited non-U.S. businesses, and refreshed nearly half of top leadership roles.

• Accelerated investments in AI, technology, and cybersecurity are improving productivity and reducing administrative burden.

• Community engagement and support initiatives expanded, especially in rural healthcare and behavioral health.

Financial highlights

• Adjusted EPS was $7.23, well ahead of expectations, with GAAP EPS of $6.90; Q1 revenue reached $111.7 billion, up 2% year-over-year.

• Operating income for Q1 2026 was $9.0 billion, with a net margin of 5.6%.

• Medical care ratio improved to 83.9% from 84.8% in Q1 2025, reflecting pricing discipline and favorable reserve development.

• Operating cost ratio was 13.8%, reflecting targeted investments in AI, technology, and customer experience.

• Operating cash flows were $8.9 billion, or 1.4x net income.

Outlook and guidance

• Full-year adjusted EPS outlook raised to greater than $18.25; GAAP EPS to exceed $17.35.

• Expect approximately two-thirds of earnings in the first half of the year, with UnitedHealthcare and Optum Health earnings front-loaded.

• Optum Insight and Optum Rx earnings are expected to be back-half weighted, with AI investments driving future growth.

• Company targets a long-term debt-to-capital ratio of ~40%, expected to be reached in the back half of 2026.

• Plans to repurchase at least $2 billion of common stock by end of Q2 2026.